Clinical Interventional Oncology

Percutaneous management of cholangiocarcinoma

Key points In general, the higher the cholangiocarcinoma (type 3 and type 4) and the more multifocal the disease/obstruction, the more likely the patient is to require percutaneous therapy/drainage rather than endoscopic drainage. The two chief indications for preoperative biliary…

Interventional management of hepatocellular carcinoma

Key points Image guided techniques are the most common invasive therapy for unresectable hepatocellular carcinoma (HCC). Level 1 evidence supports survival benefit chemoembolization. New embolic devices may offer benefits not currenlty realized. Background Hepatocellular carcinoma (HCC) is the fifth most…

Surgical management of hepatocellular carcinoma

Key points Patients with cirrhosis are at highest risk of developing hepatocellular carcinoma (HCC) and screening with sonography every 6 months is recommended. Early-stage HCC should be treated by resection, liver transplantation, or ablation. The best modality depends on tumor…

Principles of radiotherapy

Key points The clinical application of radiation oncology balances the dual goals of improved tumor control with reduced treatment-related morbidity. Over time, technological and biological advances have offered many opportunities to further reduce normal tissue complications and improve tumor control…

Principles of percutaneous ablative therapies

Key points Percutaneous image-guided tumor ablation uses the cytotoxic properties of thermal energy or electric field strength to cause cell death. The thermal ablative effect due to coagulation necrosis is generated by the Radiofrequency probe, which acts as the cathode…